Achieving commercial success in cell and gene therapy requires careful planning from the early stages of preclinical development. On August 25th, Stephen Hill, COO of Immunopharma, and Dan Kirby, CCO of Orca Bio will participate in a panel discussion about planning for commercialization across the preclinical development pipeline. The talk, sponsored by Sartorius, will be moderated by Arsalan Arif, founder and publisher of Endpoints News.
According to Endpoints Webinars, “Stephen joined Lyell in 2019 as Chief Technical Operations Officer and became the company’s Chief Operating Officer in 2021. Prior to joining Lyell, Stephen held several senior positions at AstraZeneca including Senior Vice-President, Head of Global Biologics Operations and Vice-President, Site Head. Stephen also held multiple positions at Amgen, including Vice President, Bulk Manufacturing, Executive Director, Plant Manager and Executive Director, Manufacturing Technologies. He received an MBA and a B.S. in Microbiology and B.A. in Political Science from the University of Washington.”
To register, click here.
(Source: Endpoints Webinars, July 26th, 2022)